Ma, Z.;                     Peng, L.;                     Sheng, Y.;                     Chu, W.;                     Fu, Y.    
        Anti-Inflammatory Effect of Columbianadin against D-Galactose-Induced Liver Injury In Vivo via the JAK2/STAT3 and JAK2/p38/NF-κB Pathways. Pharmaceuticals 2024, 17, 378.
    https://doi.org/10.3390/ph17030378
    AMA Style
    
                                Ma Z,                                 Peng L,                                 Sheng Y,                                 Chu W,                                 Fu Y.        
                Anti-Inflammatory Effect of Columbianadin against D-Galactose-Induced Liver Injury In Vivo via the JAK2/STAT3 and JAK2/p38/NF-κB Pathways. Pharmaceuticals. 2024; 17(3):378.
        https://doi.org/10.3390/ph17030378
    
    Chicago/Turabian Style
    
                                Ma, Zhe,                                 Lin Peng,                                 Yaoyao Sheng,                                 Wenhui Chu,                                 and Yongqian Fu.        
                2024. "Anti-Inflammatory Effect of Columbianadin against D-Galactose-Induced Liver Injury In Vivo via the JAK2/STAT3 and JAK2/p38/NF-κB Pathways" Pharmaceuticals 17, no. 3: 378.
        https://doi.org/10.3390/ph17030378
    
    APA Style
    
                                Ma, Z.,                                 Peng, L.,                                 Sheng, Y.,                                 Chu, W.,                                 & Fu, Y.        
        
        (2024). Anti-Inflammatory Effect of Columbianadin against D-Galactose-Induced Liver Injury In Vivo via the JAK2/STAT3 and JAK2/p38/NF-κB Pathways. Pharmaceuticals, 17(3), 378.
        https://doi.org/10.3390/ph17030378